Novozymes诺维信品牌怎么样 申请店铺

我要投票 Novozymes诺维信在饲料添加剂行业中的票数:176 更新时间:2025-03-14
Novozymes诺维信是哪个国家的品牌?「Novozymes诺维信」是诺维信(中国)生物技术有限公司旗下著名品牌。该品牌发源于天津,由创始人Graziela Malucelli在1994-10-05期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Novozymes诺维信品牌出海!通过在本页面挂载Novozymes诺维信品牌的产品链接和联系邮箱,可以提高Novozymes诺维信产品曝光!跨境电商爆单神器,目前只要100元/年哦~

Novozymes诺维信怎么样

诺维信公司是全球工业酶制剂和微生物制剂的主导企业,拥有超过40%的世界市场份额。2001年,诺维信公司从丹麦著名的制药公司诺和诺德公司分离出来;2004年,诺维信公司全球销售收入达到10亿美金,业务遍及130个国家。迄今为止,诺维信已经连续五年名列道琼斯可持续发展指数全球和欧洲医药/生物技术板块企业可持续发展第一名。诺维信拥有4,000多项有效专利、正在申请的专利和专利许可。在研发工作中,诺维信运用了传统微生物学、现代生物化学和分子生物学领域的多项先进核心技术,包括表达克隆、重组技术、蛋白工程和高通量筛选技术等,力争为广大客户提供所需的各种酶类。

诺维信是丹麦在华最大投资企业之一,自1994年起累计投资2亿美元,在天津经济技术开发区建立了全球酶制剂生产基地,在北京中关村科技园区设立了中国首家外资生物技术研发中心。此外,诺维信在江苏太仓建立了苏州宏达制酶有限公司;在沈阳设立了微生物生产基地;销售网络遍及全国。

中国在诺维信全球化战略中占有举足轻重的地位,已逐渐成为诺维信最重要的业务增长引擎和研发、生产及运营中心。为了更接近蓬勃发展的中国市场,以更灵活高效的方式满足中国客户的多样化需求,诺维信正在将越来越多的功能和业务重心转移到中国,并在本地广纳贤士。

在中国,诺维信秉承经营业绩、环境表现和社会责任并举的“三重底线”,积极研发适合本地市场的新产品和新应用,解决中国工业和工艺所面临的问题;同时投身地方环保事业,支持大学环境与生命科学研究及教育,倡导和推动生态工业与循环经济,立志成为中国最佳生物解决方案提供商和可持续发展的战略伙伴。

Novozyme is the leading enterprise of industrial enzyme preparation and microbial preparation in the world, with more than 40% of the world market share. In 2001, Novozymes was separated from Novo Nordisk, a famous pharmaceutical company in Denmark. In 2004, Novozymes's global sales revenue reached US $1 billion, with businesses in 130 countries. So far, Novozymes has ranked first in the world of Dow Jones sustainable development index and in the sustainable development of European pharmaceutical / biotechnology companies for five consecutive years. Novozymes has more than 4000 valid patents, patent applications and patent licenses. In the R & D work, novozyme has applied a number of advanced core technologies in the fields of traditional microbiology, modern biochemistry and molecular biology, including expression cloning, recombination technology, protein engineering and high-throughput screening technology, striving to provide customers with all kinds of enzymes they need. Novozymes is one of the largest Danish investment enterprises in China. Since 1994, Novozymes has invested 200 million US dollars in total. It has established a global enzyme production base in Tianjin Economic and Technological Development Zone and the first foreign-funded biotechnology research and development center in China in Zhongguancun Science and Technology Park, Beijing. In addition, novozyme has established Suzhou Hongda enzyme Manufacturing Co., Ltd. in Taicang, Jiangsu Province; established a microbial production base in Shenyang; and has a sales network throughout the country. China plays an important role in novozyme's global strategy and has gradually become the most important business growth engine and R & D, production and operation center of novozyme. In order to get closer to the booming Chinese market and meet the diversified needs of Chinese customers in a more flexible and efficient way, novozyme is transferring more and more functions and business focus to China and attracting talents locally. In China, Novozymes adheres to the "triple bottom line" of business performance, environmental performance and social responsibility, actively develops new products and applications suitable for the local market, and solves the problems faced by Chinese industry and technology; at the same time, Novozymes devotes itself to the local environmental protection, supports the research and education of university environment and life science, advocates and promotes the ecological industry and circular economy, and aspires to become China China's best biological solution provider and strategic partner for sustainable development.

本文链接: https://brand.waitui.com/6af0c06dc.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

3连板奇精机械:工业机器人零部件产品尚在开拓,暂未量产

36氪获悉,奇精机械公告,公司股票自2025年3月12日起连续三个交易日涨停,股价累计涨幅达33.12%。公司主营业务为家电零部件、汽车零部件及电动工具零部件三大业务板块,工业机器人零部件产品尚在开拓,暂未量产,对业绩无影响。公司基本面未发生重大变化,但可能存在非理性炒作风险。敬请广大投资者注意二级市场交易风险,理性决策,审慎投资。

2小时前

A股总市值创历史新高,突破99万亿元

3月14日A股公司总市值99.02万亿元,创历史新高,较去年年末增加5.19万亿元,增长5.53%,突破了去年11月11日98.25万亿元纪录。具体到板块来看,上证主板总市值53.95万亿元居首,深证主板总市值22.6万亿元,创业板、科创板、北交所总市值分别为13.92万亿元、7.75万亿元、7987.5亿元。(证券时报)

2小时前

兆丰股份:目前兆丰智能装备公司处于成立初期,尚未开展经营业务

36氪获悉,兆丰股份公告,公司注意到近期部分媒体平台出现一些信息将本公司与人形机器人概念相关联,现将相关事项澄清说明如下:公司此前与控股股东杭州大兆丰实业集团有限公司合资设立的“兆丰(杭州)智能装备有限公司”,旨在开展滚珠丝杠、行星滚柱丝杠的研发、制造、销售,以及轴承单元产品的研发、生产与销售。目前兆丰智能装备公司处于成立初期,尚未开展经营业务,也尚未产生业务收入,团队组建、技术研发等尚存在不确定性,短期内对公司经营业绩无重大影响,提请投资者注意投资风险。

2小时前

Stellantis将为依维柯生产两款全电动厢式货车,面向欧洲市场

3月14日,Stellantis旗下部门Stellantis Pro One宣布同依维柯达成合作,将在意大利阿泰萨、波兰格利维采和法国奥尔丹工厂生产依维柯的两款全电动厢式货车。交付后,依维柯将通过其现有销售及服务渠道在包括英国在内的欧洲市场销售这两款车型。声明称,预计新车型将在2026年年中实现商业化,供应期为十年(界面)

2小时前

远洋集团:前两个月销售额约28.8亿元,同比增42.57%

36氪获悉,远洋集团公告,2025年前两个月累计协议销售额约为人民币28.8亿元,同比增42.57%;累计协议销售楼面面积约为171,700平方米;累计协议销售均价为每平方米约人民币16,800元。

2小时前

本页详细列出关于NOVUS诺伟司的品牌信息,含品牌所属公司介绍,NOVUS诺伟司所处行业的品牌地位及优势。
咨询